Details of the Drug Reposition

General Information of This Drug (ID: DMMO9I4)

• Drug Name: ALN-AT3SC (DMMO9I4)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Haemophilia A	DIS0RQ2E	3B10.0	Phase 1	[1]
Haemophilia B	DIS6KF0Q	3B11.0	Phase 1	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)